China Site For U.S.-Based St. Jude $2.5 Million Technology Center
This article was originally published in PharmAsia News
Executive SummaryBeijing is to get a $2.5 million technology center planned by U.S.-based St. Jude Medical, maker of heart-related medical devices, including pacemakers
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.